News

Thermo Fisher to Open a New Bioprocessing Collaboration Center in St. Louis, MO

September 09, 2020

The new facility will be adjacent to Thermo Fisher’s newly expanded biologics manufacturing facility.

Catalent and Exelixis to Collaborate on ADC Development

September 09, 2020

Catalent’s Redwood Bioscience subsidiary will develop antibody-drug conjugates (ADCs) for Exelixis using Catalent’s proprietary SMARTag site-specific bioconjugation technology.

Evonik Qualifies Filling Line for Parenteral Drug Products at its Alabama Facility

September 09, 2020

The new line has the ability to aseptically fill powder, liquid, suspension, and combination forms into vials in clinical or commercial batch sizes.

AES Introduces a New Pre-Designed Cleanroom Solution

September 09, 2020

The Faciliflex Express product line can be commissioned in six months, making it ideal for cell and gene therapy companies that need to rapidly bring their therapies to patients.

AMRI Signs Agreement with AstraZeneca for COVID-19 Vaccine Delivery

September 09, 2020

AMRI will provide AstraZeneca with manufacturing capacity and sterile fill/finish services at its drug product manufacturing facility in Albuquerque, NM.

AstraZeneca Pauses Clinical Trial on COVID-19 Vaccine for Safety Review

September 08, 2020

The clinical trials of the AstraZeneca Oxford COVID-19 vaccine, AZD1222, have been paused for a safety review as a result of an incident of an unexplained illness in a UK trial patient.

Vaccine Developers Pledge to Stand with Science

September 08, 2020

As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.

FDA’s “Gold Standard” Critical for Biopharma R&D

September 08, 2020

Industry leaders insist they will maintain high standards for clinical trials and regulatory submissions for new vaccines and therapeutics to combat COVID-19.

Stevanato and Nelson Labs Team Up to Provide E&L Testing

September 03, 2020

The companies have signed a partnership agreement to provide extractables and leachables testing at the SG US Technology Excellence Center in Boston, MA.

Catalent Invests $50 Million into High-Speed Filling Line at its Bloomington Site

September 03, 2020

The new line will add capacity to Catalent’s pipeline of clinical programs and commercial launches at the site.